Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Finnegan

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Postgraduate Medical Journal|February 5, 2004
Diabetes in a high secure hospitalI A MacFarlane, G V Gill, D Finnegan, et al.
Cytogenetics and Cell Genetics|January 1, 1974
Proceedings: Analysis of the mitochondrial enzymes citrate synthase (EC 4.1.3.7) and malate dehydrogenase (EC 1.1.1.37) in human-mouse somatic cell hybridsI W Craig, V V Heuningen, D Finnegan, et al.
The Ulster Medical Journal|January 25, 2019
A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The ElderlyA B Daly, R Cuthbert, D Finnegan, et al.
International Journal of STD & AIDS|August 23, 2001
Genital schistosomiasisF M Carey, S P Quah, S Hedderwick, et al.
Nature Biotechnology|November 27, 1998
Transposition of the Drosophila element mariner into the chicken germ lineA Sherman, A Dawson, C Mather, et al.
Leukemia|February 1, 1993
In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiencyR Gunther, L M Chelstrom, D Finnegan, et al.
Leukemia & Lymphoma|April 1, 1993
Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxinF M Uckun, D E Myers, J D Irvin, et al.
Blood|June 15, 1992
Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamideF M Uckun, L M Chelstrom, D Finnegan, et al.
Blood|May 1, 1992
In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiencyF M Uckun, C Manivel, D Arthur, et al.
Blood|May 15, 1992
In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemiaF M Uckun, L M Chelstrom, J D Irvin, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Postgraduate Medical Journal|February 5, 2004
Diabetes in a high secure hospitalI A MacFarlane, G V Gill, D Finnegan, et al.
Cytogenetics and Cell Genetics|January 1, 1974
Proceedings: Analysis of the mitochondrial enzymes citrate synthase (EC 4.1.3.7) and malate dehydrogenase (EC 1.1.1.37) in human-mouse somatic cell hybridsI W Craig, V V Heuningen, D Finnegan, et al.
The Ulster Medical Journal|January 25, 2019
A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The ElderlyA B Daly, R Cuthbert, D Finnegan, et al.
International Journal of STD & AIDS|August 23, 2001
Genital schistosomiasisF M Carey, S P Quah, S Hedderwick, et al.
Nature Biotechnology|November 27, 1998
Transposition of the Drosophila element mariner into the chicken germ lineA Sherman, A Dawson, C Mather, et al.
Leukemia|February 1, 1993
In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiencyR Gunther, L M Chelstrom, D Finnegan, et al.
Leukemia & Lymphoma|April 1, 1993
Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxinF M Uckun, D E Myers, J D Irvin, et al.
Blood|June 15, 1992
Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamideF M Uckun, L M Chelstrom, D Finnegan, et al.
Blood|May 1, 1992
In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiencyF M Uckun, C Manivel, D Arthur, et al.
Blood|May 15, 1992
In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemiaF M Uckun, L M Chelstrom, J D Irvin, et al.
Pageof 3